Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simulation and empirical evaluation of biologically-informed neural network performance.

Machine learning with applications·2026
Same author

A critical response to the mental health commission's guidance for staff working in mental health services on the care and treatment of LGBTQIA+ people.

Irish journal of psychological medicine·2026
Same author

Simulation and empirical evaluation of biologically-informed neural network performance.

bioRxiv : the preprint server for biology·2025
Same author

Transgender and Gender-Diverse Patient Perspectives on Hereditary Breast Cancer Risk Assessment in Gender-Affirming Top Surgeries.

JCO precision oncology·2025
Same author

Prolonged Length of Hospital Stay and Delayed Discharges Among Patients Referred to Child Psychiatry Liaison Services: A 5-Year Retrospective Analysis.

The Journal of pediatrics·2025
Same author

Nivolumab plus low-dose ipilimumab in hypermutated HER2-negative metastatic breast cancer: a phase II trial (NIMBUS).

Nature communications·2025

Related Experiment Video

Updated: Oct 30, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K

Clinical Multigene Testing for Prostate Cancer.

Tala Berro1, Elizabeth Barrett2, Saud H AlDubayan3

  • 1Division of Genetics, Brigham and Women's Hospital, EC Alumnae Hall, Suite 302, 41 Avenue Louis Pasteur, Boston, MA 02115, USA. Electronic address: https://twitter.com/tala_berro.

The Urologic Clinics of North America
|July 2, 2021
PubMed
Summary
This summary is machine-generated.

Germline genetic testing for prostate cancer (PC) is crucial for understanding treatment options. More research is needed as current studies on PC patients are limited compared to the disease

Keywords:
Genetic counselingGermline genetic testingMultigene panel testingProstate cancer

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.0K

Related Experiment Videos

Last Updated: Oct 30, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.4K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.0K

Area of Science:

  • Oncology
  • Genetics
  • Medical Diagnostics

Background:

  • Germline genetic testing for prostate cancer (PC) is gaining clinical importance.
  • Understanding germline variants improves patient care strategies.

Purpose of the Study:

  • To review the clinical landscape of germline genetic testing in prostate cancer patients.
  • To identify limitations and pathogenic findings in existing studies.

Main Methods:

  • Systematic review of published clinical cohorts of prostate cancer patients undergoing germline genetic analysis.
  • Analysis of reported pathogenic germline variants and their clinical utility.

Main Results:

  • Highlighted limitations and heterogeneity in current clinical cohorts.
  • Identified pathogenic germline results with established or potential clinical utility in PC.

Conclusions:

  • The number of prostate cancer patients studied with germline genetics lags behind the disease's prevalence.
  • Further germline genetic studies are essential for advancing PC management.